Approvals/TGA/CIPLA PACLITAXEL Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial

Approved

STANDARD

CIPLA PACLITAXEL Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 263d0f232af717b0
Product Name: CIPLA PACLITAXEL Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial
Artg Id: 328529
Artg Name: CIPLA PACLITAXELPaclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2020-10-29
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

263d0f232af717b0

Type

Standard